Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiographic appearance of leptomeningeal disease in patients with EGFR-mutated non-small-cell lung carcinoma treated with tyrosine kinase inhibitors: A case series
    Journal Article

    Sener, U.; Matin, N.; Yu, H.; Lin, A.; Yang, T. J.; Malani, R.
    CNS Oncology (2019)

    Fulltext@MSK | Save
  • Generation and characterization of patient-derived preclinical models from tumor cells isolated from cerebrospinal fluid
    Meeting Abstract

    Offin, M.; Vojnic, M.; Liu, Z.; Lui, A.; Siau, E.; Gladstone, E.; Mattar, M.; Khodos, I.; Drilon, A.; Boire, A.; more...
    Neuro-Oncology Advances (2019)

    Fulltext@MSK | Save
  • Long-term survival outcomes with nivolumab (NIVO) in patients with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
    Meeting Abstract

    Wohlleber, M.; Brahmer, J.; Borghaei, H.; Ramalingam, S. S.; Horn, L.; Carpeño, J. D.; Pluzanski, A.; Burgio, M. A.; Garassino, M.; Chow, L. Q. M.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
    Meeting Abstract

    Blattmann, C.; Albert, C. M.; Kummar, S.; van Tilburg, C. M.; Dubois, S. G.; Geoerger, B.; Mascarenhas, L.; Federman, N.; Schilder, R. J.; Doz, F.; more...
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Harmonization of tumor mutational burden quantification and association with response to immune checkpoint blockade in non-small-cell lung cancer
    Journal Article

    Vokes, N. I.; Liu, D.; Ricciuti, B.; Jimenez-Aguilar, E.; Rizvi, H.; Dietlein, F.; He, M. X.; Margolis, C. A.; Elmarakeby, H. A.; Girshman, J.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Rapid non-uniform adaptation to conformation-specific KRAS G12C inhibition
    Meeting Abstract

    Xue, J.; Zhao, Y.; Aronowitz, J.; Mai, T. T.; Vides, A.; Qeriqi, B.; Kim, D.; Li, C.; de Stanchina, E.; Mazutis, L.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumors
    Meeting Abstract

    Doz, F.; Geoerger, B.; DuBois, S. G.; Grilley-Olson, J. E.; van Tilburg, C. M.; Italiano, A.; Lissat, A.; Kang, H. J.; Tahara, M.; Boni, V.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Modern management of central nervous system metastases in the era of targeted therapy and immune oncology
    Review

    Brastianos, P.; Davies, M. A.; Margolin, K.; Yu, H. A.
    American Society of Clinical Oncology Educational Book (2019)

    Fulltext@MSK | Save